China Relaxes Restrictions Amid 'Zero' Severe Shanghai Cases
Paxlovid Struggling?
China is signalling its intention to gradually re-open its borders amid real-world data showing few mild-to-moderate cases progress to severe symptoms. Meanwhile, Pfizer's Paxlovid is seemingly struggling to gain traction amid use guideline changes.
